Problems related to systemic glucocorticoid therapy in children

Area of Science:

• Rheumatology
• Pharmacology
• Pediatrics

Background:

• Glucocorticoids (GC) are highly effective anti-inflammatory agents for rheumatic diseases.
• Their therapeutic benefits are linked to complex and multifaceted mechanisms of action.
• Systemic GC use is associated with a broad spectrum of side effects, including growth suppression in children.

Purpose of the Study:

• To outline recommendations for optimizing Glucocorticoid (GC) prescription in rheumatic diseases.
• To minimize the incidence and severity of GC-related side effects.
• To provide guidance for safe and effective GC use, particularly in pediatric populations.

Main Methods:

• Review of established clinical guidelines and pharmacological data on Glucocorticoid (GC) use.
• Analysis of side effect profiles associated with systemic GC therapy.
• Synthesis of evidence-based recommendations for optimizing GC prescribing practices.

Main Results:

• GCs offer potent anti-inflammatory effects crucial for managing rheumatic conditions.
• Significant side effects, such as growth suppression, necessitate careful dosing and monitoring.
• Adherence to specific prescribing strategies can mitigate adverse events.

Conclusions:

• Optimized Glucocorticoid (GC) therapy involves using the lowest effective dose for established indications.
• Alternate-day or single-daily administration and concomitant use of steroid-sparing agents are recommended.
• Selecting GCs with favorable side effect profiles is crucial for patient safety, especially in pediatric rheumatic diseases.